• 제목/요약/키워드: Gene delivery carrier

검색결과 42건 처리시간 0.032초

Intravenous and Intra-arterial Delivery of Plasmid DNA/Cationic Lipiodol Emulsion Complexes

  • Chae, Min-Jung;Chung , Hes-Son;Kwon, Ick-Chan;Chung, Jin-Wook;Park, Jae-Hyung;Sohn, Young-Taek;Jeong, Seo-Young
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.226.3-227
    • /
    • 2003
  • A cationic lipid emulsion (o/w) containing lipiodol and 1, 2-dioleoyl-sn- glycero-3-trimethylammonium-propane (DOTAP) has been prepared as a gene delivery system. In order to increase the transfection efficiency of the lipiodol emulsion, 1 2-dioleoyl-sn-glycero-3-phospho-ethanolamine (DOPE) and polyoxyethylene sorbitan monooleate (Tween 80) were incorporated as additional lipids. By including DOPE and Tween 80, the cationic emulsion became a more potent gene carrier under in vitro condition in the presence of serum, and under in vivo condition. (omitted)

  • PDF

Hyaluronic Acid in Drug Delivery Systems

  • Jin, Yu-Jin;Ubonvan, Termsarasab;Kim, Dae-Duk
    • Journal of Pharmaceutical Investigation
    • /
    • 제40권spc호
    • /
    • pp.33-43
    • /
    • 2010
  • Hyaluronic acid (HA) is a biodegradable, biocompatible, non-toxic, non-immunogenic and non-inflammatory linear polysaccharide, which has been used for various medical applications including arthritis treatment, wound healing, ocular surgery, and tissue augmentation. Because of its mucoadhesive property and safety, HA has received much attention as a tool for drug delivery system development. It has been used as a drug delivery carrier in both nonparenteral and parenteral routes. The nonparenteral application includes the ocular and nasal delivery systems. On the other hand, its use in parenteral systems has been considered important as in the case of sustained release formulation of protein drugs through subcutaneous injection. Particles and hydrogels by various methods using HA and HA derivatives as well as by conjugation with other polymer have been the focus of many studies. Furthermore, the affinity of HA to the CD44 receptor which is overexpressed in various tumor cells makes HA an important means of cancer targeted drug delivery. Current trends and development of HA as a tool for drug delivery will be outlined in this review.

non-viral gene delivery mediated by chitosan and PEl: developement of a gene carrier with serum stability and reduced cytotoxicity

  • Kim, Mi-Na;Hyun, Min-Sang;Jiang, Ge;Chung, Kyeong-Soo;Yeom, Young-Il
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.277.1-277.1
    • /
    • 2002
  • The purpose of this study was to develop PEl-based gene carriers with optimal serum stability and reduced cytotoxicity. PEl is an efficient gene transfer agent with the ability of DNA condensation and endosome escape: however; use of the polymer in vivo is hampered by signigicant reduction in transfection activity by the presence of serum. Chitosan is a non-toxic. biodegradable and biocompatible polymer with hydrophilic functional groups so it may provide a physical stability against challenge by serum proteins. (omitted)

  • PDF

Induction of Immunity Against Hepatitis B Virus Surface Antigen by Intranasal DNA Vaccination Using a Cationic Emulsion as a Mucosal Gene Carrier

  • Kim, Tae Woo;Chung, Hesson;Kwon, Ick Chan;Sung, Ha Chin;Kang, Tae Heung;Han, Hee Dong;Jeong, Seo Young
    • Molecules and Cells
    • /
    • 제22권2호
    • /
    • pp.175-181
    • /
    • 2006
  • Delivery of DNA vaccines to airway mucosa would be an ideal method for mucosal immunization. However, there have been few reports of a suitable gene delivery system. In this study we used a cationic emulsion to immunize mice via the intranasal route with pCMV-S coding for Hepatitis B virus surface antigen (HBsAg). Complexing pCMV-S with a cationic emulsion dramatically enhanced HBsAg expression in both nasal tissue and lung, and was associated with increases in the levels of HBs-specific Abs in serum and mucosal fluids, of cytotoxic T lymphocytes (CTL) in the spleen and cervical and iliac lymph nodes, and of delayed-type hypersensitivity (DTH) against HBsAg. In contrast, very weak humoral and cellular immunities were observed following immunization with naked DNA. In support of these observations, a higher proliferative response of spleenocytes was detected in the group immunized with the emulsion/pCMV-S complex than in the group immunized with naked pCMV-S. These findings may facilitate development of an emulsion-mediated gene vaccination technique for use against intracellular pathogens that invade mucosal surfaces.

Folate-PEG-DPPE를 포함하는 양이온성 지질 에멀젼 시스템의 표적화 유전자 전달 (Targeted Gene Delivery of the Cationic Lipid Emulsion System Containing Folate-PEG-DPPE)

  • 권상규;정관호;김영진
    • 폴리머
    • /
    • 제33권3호
    • /
    • pp.213-218
    • /
    • 2009
  • 1,2-Dioleoyl-3-trimethylammonium-propane(DOTAP)와 Tween80, squalene을 포함하는 양이온성 지질 에멀젼을 기반으로 효율적인 비바이러스성 유전자 전달체를 개발하였다. 유전자 전달체의 발현효율을 증가시키기 위해 암세포에 표적지향성을 가지는 folate를 수식한 PEG-DPPE를 사용하였다. Folate-PEG-DPPE를 포함하는 양이온성 지질 에멀젼으로 HeLa 세포주와 293 세포주에 유전자 형질발현 실험을 하였다. HeLa 세포는 folate에 민감한 세포주이다. 양이온성 지질 에멀젼의 입자필기와 DNA/lipid 복합체의 크기는 각각 205.6 nm와 150.5 nm로 측정되었다. 양이온성 지질 시스템/DNA(4:1(w:w)) 복합체의 유전자 발현효율은 folate의 표적화 영향으로 인해 DOTAP만 있는 에멀젼에 비하여 100배 이상 더 높은 것으로 나타났다.

사이토카인 유전자 함유 바이러스 유사입자의 제조 (Virus-like Particles Containing Cytokine Plasmid DNA)

  • 오유경;손태종;신광숙;강민정;김정목;김남근;고정재;김종국
    • Journal of Pharmaceutical Investigation
    • /
    • 제31권3호
    • /
    • pp.185-190
    • /
    • 2001
  • Human papillomavirus (HPV) infection is known to cause cervical cancers. Human papillomavirus-like particles (VLP) have been studied as preventive vaccines of cervical cancers. To develop VLP as a therapeutic gene carrier, we studied the method to encapsulate cytokine genes in virus-like particles. HPV type 16 capsid L1 genes were amplified by polymerase chain reaction and cloned into T vector. L1 gene was then inserted into baculovirus transfer vector. The clone of baculovirus encoding L1 gene was isolated and used to express L1 protein in Sf 21 insect cells. VLP were purified by CsCl density gradient and ultracentrifugation. VLP were disassembled to capsomer units by treatment of a reducing agent. Given that interleukin-2 (IL-2) genes have been used in anticancer gene therapy and as a molecular adjuvant, IL-2 cytokine plasmids were chosen as a model gene. IL-2 plasmids were incubated with the disassembled capsomer suspension. To reassemble the particles, the mixture of capsomers and cytokine plasmids was dialyzed. The disassembly and reassembly of VLP were confirmed by transmission electron microscopy. The entrapment of cytokine plasmids in reassembled VLP was tested by the stability of plasmids against DNase I. After treatment of reassembled virus-like particles with DNase I, discrete IL-2 DNA band was observed. Our results indicate that IL-2 cytokine plasmid (3.5 kb size) can be encapsulated in the virus-like particles, suggesting the potential of VLP as a gene delivery system. Moreover, VLP containing the adjuvant cytokine plasmids might function as more effective subunit vaccines.

  • PDF

폴리디아세틸렌 리포좀 표면에 저분자량의 폴리에틸렌이민을 연결한 새로운 유전자 전달체 합성 및 특징 연구 (Synthesis and Characterization of Polyethylenimine-conjugated Polydiacetylene Liposome as a Gene Delivery Carrier)

  • 이영화;임강혁;허정석;최준식
    • 폴리머
    • /
    • 제38권1호
    • /
    • pp.43-48
    • /
    • 2014
  • 본 논문은 저분자량의 폴리에틸렌이민을 폴리디아세틸렌 리포좀 표면에 연결하여 유전자를 세포 내로 전달할 수 있는 새로운 양이온성 고분자 리포좀 유전자 전달체 개발에 대한 결과이다. 폴리디아세틸렌 리포좀 제조 후에 자외선을 조사하여 고분자성 리포좀을 제조한 후, 유전자의 전달 효율을 높이기 위해 폴리에틸렌이민을 리포좀 표면에 커플링제를 이용하여 공유결합시켜서 PCDA-PEI 리포좀을 합성하였다. 제조한 고분자 리포좀을 이용하여 동물세포 내에서의 유전자 전달 및 발현 효율과 그에 따른 독성을 확인하는 연구를 수행하였다. 사용한 폴리에틸렌이민은 가지형이고 분자량은 2 kD인 것을 사용하였다. DNA와의 복합체 형성을 알아보기 위하여 전기영동 방법과 피코그린 형광 염색 시약을 사용하였으며 효율적으로 복합체를 형성하는 것을 확인하였다. 전달체의 효율과 독성을 확인하기 위하여 HEK 293 및 HeLa 세포를 사용하여 확인하였다. 실험 결과 PCDA-PEI 리포좀은 세포 내에서 비율이 높아질수록 유전자 전달 효율이 증가하는 경향을 보였고, 세포에 대한 독성도 상대적으로 낮음을 확인하였다. 이러한 결과는 PCDA-PEI 리포좀이 효율적인 유전자 혹은 약물 전달체로 사용될 수 있음을 보여주었다.

Galactosylated Chitosan (GC)-graft-Poly(vinyl pyrrolidone) (PVP) as Hepatocyte-Targeting DNA Carrier: In Vitro Transfection

  • Park, In-Kyu;Jiang, Hu-Lin;Cook, Seung-Eun;Cho, Myung-Haing;Kim, Su-Il;Jeong, Hwan-Jeong;Akaike, Toshihiro;Cho , Chong-Su
    • Archives of Pharmacal Research
    • /
    • 제27권12호
    • /
    • pp.1284-1289
    • /
    • 2004
  • Galactosylated chitosan-graft-poly(vinyl pyrrolidone) (GCPVP) was synthesized and characterized for hepatocyte-targeting gene carrier. GCPVP itself as well as GCPVP/DNA complex had negligible cytotoxicity regardless of the concentration of GCPVP and the charge ratio, but GCPVP/DNA complex had slightly cytotoxic effect on HepG2 cells only in the case of the higher charge ratio and 20 mM of $Ca^{2+}$ concentration used. Through the confocal laser scanning microscopy, it is shown that the endocytosis by interaction between galactose ligands of GCPVP and ASGPR of the hepatocytes was the major route of transfection of GCPVP/F-plasmid complexes.

Delivery of Hypoxia Inducible Heme Oxygenase-1 Gene Using Dexamethasone Conjugated Polyethylenimine for Protection of Cardiomyocytes under Hypoxia

  • Kim, Hyun-Jung;Kim, Hyun-Ah;Choi, Joon-Sig;Lee, Min-Hyung
    • Bulletin of the Korean Chemical Society
    • /
    • 제30권4호
    • /
    • pp.897-901
    • /
    • 2009
  • Heme oxygenase-1 (HO-1) is an anti-inflammatory and anti-apoptotic protein and has been applied to various gene therapy researches. However, constitutive expression of HO-1 may induce deleterious side effects. In this research, hypoxia inducible HO-1 expression plasmid, pEpo-SV-HO-1, was constructed with the erythropoietin (epo) enhancer and simian virus 40 (SV40) promoter to avoid these unwanted side effects. Dexamethasone conjugated polyethylenimine (PEI-Dexa) was used as a gene carrier. It was previously reported that dexamethasone protected cardiomyocytes from apoptosis under hypoxia. In this research, PEI-Dexa reduced the caspase-3 level in hypoxic H9C2 cardiomyocytes as a derivative of dexamethasone, suggesting that PEI-Dexa is an anti-apoptotic reagent as well as a gene carrier. pEpo-SV-HO-1 was transfected to H9C2 cardiomyocytes using PEI-Dexa and the cells were incubated under normoxia or hypoxia. HO-1 expression was induced in the pEpo-SV-HO-1 transfected cells under hypoxia. In addition, cell viability under hypoxia was higher in the pEpo-SV-HO-1 transfected cells than the pEpo-SV-Luc transfected cells. Also, caspase-3 level was reduced in the pEpo-SV-HO-1 transfected cells under hypoxia. In addition to the anti-apoptotic effect of PEI-Dexa, hypoxia inducible HO-1 expression by pEpo-SVHO- 1 may be helpful to protect cardiomyocytes under hypoxia. Therefore, pEpo-SV-HO-1/PEI-Dexa complex may be useful for ischemic heart disease gene therapy.

마이크로/나노-운반체를 이용한 톡소이드 항원의 효과적인 전달 방법 (Efficient Delivery of Toxoid Antigens using Micro/Nano-carriers)

  • 박가영;안근아;이세희;김상범;김양훈;안지영
    • 생명과학회지
    • /
    • 제28권4호
    • /
    • pp.496-507
    • /
    • 2018
  • 톡소이드는 독성은 제거되고 항원성은 유지시킨 독소 단백질로써, 다양한 병원체의 감염 및 질병 예방을 위해 지속적으로 연구 되었다. 그러나, 톡소이드의 활성 감소 및 이와 함께 사용하는 어쥬번트의 부작용 등이 지속적으로 보고되면서, 면역성은 강화하고 어쥬번트의 사용은 줄일 수 있는 톡소이드 항원 전달 시스템이 필요하게 되었다. 따라서, 이러한 단점을 개선하고자 최근 새로운 백신과 약물 전달수송을 위해 다양한 분야에서 활용하고 있는 마이크로/나노 운반체를 톡소이드 항원에 도입하고 있다. 이와 같은 마이크로/나노 운반체는 미생물 자체를 이용하거나 미생물을 통해 생산해 낼 수도 있으며, 더 나아가 다양한 소재의 폴리머를 이용하여 제작할 수 있다. 본 총설에서는 톡소이드 항원 전달을 위한 마이크로/나노 운반체를 미생물 유래의 ghost cells (GCs), 그람 음성 세균이 분비하는 outer membrane vesicles (OMVs) 및 고분자 폴리머로 구성된 nanoparticles (NPs)으로 분류하였다. 마지막으로 각 운반체에 대한 톡소이드 항원의 전달 방식 및 이를 적용하였을 때 일어나는 면역반응에 대하여 서술하였으며, 이를 통해 향후 톡소이드의 효율 및 부작용이 개선되기를 기대한다.